GeRIatric Multidisciplinary Meeting (GRIMM)

July 5, 2018 updated by: University Hospital, Angers

Modeling of the Geriatric Multidisciplinary Meeting of the Angers University Hospital

The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile.

The secondary objectives are:

  • To distinguish the different types of answers given by the GMM according to the demands and situations.
  • To study the factors associated with the orientation proposed by the GMM
  • To examine the adequacy between the orientation proposed by the GMM and the pathway actually taken
  • To compare the diagnoses made during the following year with the data collected during the GMM

Study Overview

Status

Completed

Conditions

Detailed Description

Increasing attention is paid to care pathways for elderly according to the principle of good care applied to the right patient at the right time and in the most appropriate care structure.

Since 2007, the geriatric mobile team (GMT) of the Angers University Hospital has formalized a geriatric multidisciplinary meeting (GMM) in connection with the geriatric network and branch of the geographical sector, in order to optimize the provision of care for elderly patients at the territorial level.

The weekly GMM brings together physicians from the geriatric department (GMT, acute care unit), memory center, long-term care and skilled nursing facilities, cognitive behavioral unit, psychiatry, retirement home, the local geriatric network of the city of Angers, the local information and coordination center, the home for autonomy and integration of Alzheimer patients (MAIA) and specialized Alzheimer (ESA) teams. Requests come either University Hospital services or from outside, via a standardized form. If necessary, additional data collection is carried out before the meeting by telephone with the patient, his family or the general practitioner. A letter explaining the decision of the GMM is sent to the applicant physician and to the general practitioner and recorded in the patient file.

Collegial guidance decisions within the health care system seem to follow implicit rules. Given the growing number of files presented, the investigators want to theorize the adopted mode of reflection.

Study Type

Observational

Enrollment (Actual)

734

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • Angers University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

64 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients are recruited during the GMM of the University Hospital of Angers, France

Description

Inclusion Criteria:

  • All the files discussed in GMM in the year 2015 following a request for geriatric care addressed to the Geriatrics department of the UH

Exclusion Criteria:

  • No one

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The demographic characteristics and medico-social data provided by the physician and the family at the time of the consultation request
Time Frame: baseline
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The answer given by the GMM
Time Frame: baseline
This outcome is assessed by the guidance proposal issued by GMM
baseline
The orientation proposed by the GMM
Time Frame: baseline
The recommendations made by GMM
baseline
The adequacy between the orientation proposed by the GMM and the pathway actually taken : back in the previous structure, hospitalization, reorientation, entry to a nursing home, other :
Time Frame: baseline and during the following year
The course of care carried out at the Angers UH after the GMM
baseline and during the following year
The diagnoses made during the following year with the data collected during the GMM : Alzheimer's disease, mixed dementia, body lewy, Parkinson's disease, frontotemporal dementia, vascular dementia, other
Time Frame: baseline and during the following year
Diagnoses carried out at the Angers UH after the GMM
baseline and during the following year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2017

Primary Completion (Actual)

September 4, 2017

Study Completion (Actual)

September 4, 2017

Study Registration Dates

First Submitted

October 26, 2017

First Submitted That Met QC Criteria

July 5, 2018

First Posted (Actual)

July 6, 2018

Study Record Updates

Last Update Posted (Actual)

July 6, 2018

Last Update Submitted That Met QC Criteria

July 5, 2018

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-06

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe